• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性多中心 Castleman 病合并干燥综合征及继发膜性肾病:病例报告及文献复习。

Idiopathic multicentric Castleman disease with Sjögren's syndrome and secondary membranous nephropathy: a case report and review of the literature.

机构信息

Department of Nephrology, Peking University Third Hospital, 49 Huayuanbei Road, Beijing, 100191, PR China.

出版信息

BMC Nephrol. 2020 Dec 4;21(1):528. doi: 10.1186/s12882-020-02191-z.

DOI:10.1186/s12882-020-02191-z
PMID:33276741
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7718671/
Abstract

BACKGROUND

Idiopathic multicentric Castleman disease (iMCD) is an uncommon lymphoproliferative disorder and lacks treatment consensus. Herein, we report a case of iMCD complicated with Sjögren's syndrome (SS) and secondary membranous nephropathy (SMN).

CASE PRESENTATION

A 45-year-old female with dry mouth for 3 months and anasarca and proteinuria for 2 months was admitted. She also experienced chest tightness, wheezing, fever, weight loss, moderate proteinuria and hypoalbuminemia. A computed tomography (CT) scan revealed a tissue mass in the thymus area and enlarged multiple lymph nodes. Her symptoms did not improve after resection of the thymus mass. The pathological findings were "reactive hyperplasia of the mediastinal lymph nodes and thymic hyperplasia". Lymph node biopsy findings confirmed iMCD with human herpes virus-8 (HHV-8) negativity. Based on anti-nuclear antibody (ANA) 1:320, anti-SSA and anti-SSB antibody positivity, salivary flow less than 0.1 ml/min and lip biopsy with focal lymphocytic sialadenitis, SS was diagnosed. Kidney biopsy showed secondary membranous nephropathy with endocapillary cell proliferation and infiltration of plasma cells and lymphocytes in the tubulointerstitium. Serum interleukin-6 (IL-6) levels were significantly increased, and therapy with tocilizumab (anti-IL-6 receptor antibody) worked well. The combination of cyclophosphamide (CyS) with methylprednisolone (MP) maintained satisfactory remission.

CONCLUSIONS

Our case of iMCD with SS and SMN is rare. There is a need for increased awareness of the disease to avoid unnecessary procedures and misdiagnoses. IL-6 was extremely high, and there was a rapid response to anti-IL-6 receptor agents. The combination of CyS with MP maintained complete remission.

摘要

背景

特发性多中心 Castleman 病(iMCD)是一种罕见的淋巴组织增生性疾病,目前尚无治疗共识。在此,我们报告一例 iMCD 合并干燥综合征(SS)和继发性膜性肾病(SMN)。

病例介绍

一名 45 岁女性,因口干 3 个月,浮肿和蛋白尿 2 个月入院。她还伴有胸闷、喘息、发热、体重减轻、中度蛋白尿和低白蛋白血症。计算机断层扫描(CT)显示胸腺区有组织肿块和多个淋巴结肿大。切除胸腺肿块后,她的症状并未改善。病理检查结果为“纵隔淋巴结反应性增生和胸腺增生”。淋巴结活检结果证实为 iMCD,人类疱疹病毒-8(HHV-8)阴性。基于抗核抗体(ANA)1:320、抗 SS-A 和抗 SS-B 抗体阳性、唾液流量小于 0.1ml/min 和唇活检有局灶性淋巴细胞性涎腺炎,诊断为 SS。肾活检显示继发性膜性肾病,伴有毛细血管内细胞增殖和肾小管间质中浆细胞和淋巴细胞浸润。血清白细胞介素-6(IL-6)水平显著升高,使用托珠单抗(抗 IL-6 受体抗体)治疗效果良好。环磷酰胺(CyS)联合甲基强的松龙(MP)的联合治疗维持了令人满意的缓解。

结论

我们报告的 iMCD 合并 SS 和 SMN 病例较为罕见。需要提高对该病的认识,以避免不必要的检查和误诊。IL-6 极高,对抗 IL-6 受体药物有快速反应。CyS 联合 MP 可维持完全缓解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/918f/7718671/89cbfad2c782/12882_2020_2191_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/918f/7718671/b2db41bb5767/12882_2020_2191_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/918f/7718671/40a036f8abef/12882_2020_2191_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/918f/7718671/89cbfad2c782/12882_2020_2191_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/918f/7718671/b2db41bb5767/12882_2020_2191_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/918f/7718671/40a036f8abef/12882_2020_2191_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/918f/7718671/89cbfad2c782/12882_2020_2191_Fig3_HTML.jpg

相似文献

1
Idiopathic multicentric Castleman disease with Sjögren's syndrome and secondary membranous nephropathy: a case report and review of the literature.特发性多中心 Castleman 病合并干燥综合征及继发膜性肾病:病例报告及文献复习。
BMC Nephrol. 2020 Dec 4;21(1):528. doi: 10.1186/s12882-020-02191-z.
2
Two cases of idiopathic multicentric Castleman disease with nephrotic syndrome treated with tocilizumab.两例特发性多中心 Castleman 病伴肾病综合征患者采用托珠单抗治疗。
CEN Case Rep. 2021 Feb;10(1):35-41. doi: 10.1007/s13730-020-00511-8. Epub 2020 Jul 26.
3
Membranous nephropathy associated with multicentric Castleman's disease that was successfully treated with tocilizumab: a case report and review of the literature.与多发性 Castleman 病相关的膜性肾病,经托珠单抗治疗后成功:病例报告及文献复习。
BMC Nephrol. 2021 Jun 9;22(1):216. doi: 10.1186/s12882-021-02423-w.
4
Membranous nephropathy with thrombotic microangiopathy-like lesions successfully treated with tocilizumab in a patient with idiopathic multicentric Castleman disease.特立昔珠单抗治疗特发性多中心 Castleman 病伴血栓性微血管病样病变膜性肾病一例
CEN Case Rep. 2021 May;10(2):265-272. doi: 10.1007/s13730-020-00559-6. Epub 2021 Jan 2.
5
[A case of Sjögren's syndrome complicated by membranous nephropathy].1例干燥综合征合并膜性肾病
Nihon Jinzo Gakkai Shi. 1996 Sep;38(9):413-6.
6
Sjögren's syndrome with ANCA-associated crescentic extramembranous glomerulonephritis.干燥综合征合并抗中性粒细胞胞浆抗体相关的新月体性膜外肾小球肾炎。
Joint Bone Spine. 2009 Mar;76(2):188-9. doi: 10.1016/j.jbspin.2008.05.010. Epub 2009 Feb 3.
7
[Membranous glomerulonephritis during primary Gougerot-Sjögren syndrome].[原发性干燥综合征合并膜性肾小球肾炎]
Presse Med. 2005 Sep 10;34(15):1069-72. doi: 10.1016/s0755-4982(05)84118-1.
8
Multicentric Castleman's disease in a patient with primary Sjögren's syndrome.一名原发性干燥综合征患者的多中心性Castleman病。
Rheumatol Int. 1993;12(6):251-3. doi: 10.1007/BF00301012.
9
Sjögren's syndrome complicated with membranous nephropathy, a cause or coincidence?干燥综合征合并膜性肾病,是病因还是巧合?
Int J Rheum Dis. 2021 Aug;24(8):1086-1094. doi: 10.1111/1756-185X.14168. Epub 2021 Jul 5.
10
Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA/Ro and anti-SSB/La antibodies in Sjögren's syndrome?吸烟患者中局灶性唇涎腺炎的发生率较低(灶性评分)。从组织学检查以及干燥综合征患者的抗SSA/Ro和抗SSB/La抗体判断,烟草会减轻唾液腺受累情况吗?
Ann Rheum Dis. 2000 Jan;59(1):54-60. doi: 10.1136/ard.59.1.54.

引用本文的文献

1
Case Report: TAFRO syndrome misdiagnosed as liver cirrhosis due to persistent abdominal distension.病例报告:因持续性腹胀被误诊为肝硬化的TAFRO综合征
Front Immunol. 2025 Apr 3;16:1554198. doi: 10.3389/fimmu.2025.1554198. eCollection 2025.
2
Common connective tissue disorder and anti-cytokine autoantibodies are enriched in idiopathic multicentric castleman disease patients.常见的结缔组织疾病和抗细胞因子自身抗体在特发性多中心Castleman病患者中富集。
Front Immunol. 2025 Mar 13;16:1528465. doi: 10.3389/fimmu.2025.1528465. eCollection 2025.
3
Multicentric Castleman Disease: A Case Report of an Arab Female.

本文引用的文献

1
Two cases of idiopathic multicentric Castleman disease with nephrotic syndrome treated with tocilizumab.两例特发性多中心 Castleman 病伴肾病综合征患者采用托珠单抗治疗。
CEN Case Rep. 2021 Feb;10(1):35-41. doi: 10.1007/s13730-020-00511-8. Epub 2020 Jul 26.
2
Multicentric Castleman disease with TAFRO syndrome and Sjögren's.伴有TAFRO综合征和干燥综合征的多中心Castleman病
Clin Case Rep. 2019 Oct 24;7(12):2388-2392. doi: 10.1002/ccr3.2502. eCollection 2019 Dec.
3
Diagnosis and Management of Castleman Disease.《卡斯特曼病的诊断与治疗》。
多中心性Castleman病:一名阿拉伯女性病例报告
Cureus. 2024 Oct 8;16(10):e71112. doi: 10.7759/cureus.71112. eCollection 2024 Oct.
4
Castleman's disease in the rheumatological practice.风湿科临床中的卡斯尔曼病
Z Rheumatol. 2024 Dec;83(Suppl 3):289-298. doi: 10.1007/s00393-024-01560-5. Epub 2024 Aug 22.
5
Development of a nomogram for membranous nephropathy prediction in patients with primary Sjögren's syndrome: a 6-year retrospective study.原发性干燥综合征患者膜性肾病预测的列线图的建立:一项 6 年回顾性研究。
Front Immunol. 2024 Apr 3;15:1320880. doi: 10.3389/fimmu.2024.1320880. eCollection 2024.
6
TAFRO syndrome is associated with anti-SSA/Ro60 antibodies, in contrast to idiopathic castleman disease.与特发性Castleman病相反,TAFRO综合征与抗SSA/Ro60抗体相关。
Sci Rep. 2024 Feb 5;14(1):2889. doi: 10.1038/s41598-024-53413-5.
7
How to Choose the Right Treatment for Membranous Nephropathy.如何为膜性肾病选择正确的治疗方法。
Medicina (Kaunas). 2023 Nov 14;59(11):1997. doi: 10.3390/medicina59111997.
8
[Castleman's disease in the rheumatological practice].[风湿科临床中的Castleman病]
Z Rheumatol. 2024 May;83(4):316-326. doi: 10.1007/s00393-023-01393-8. Epub 2023 Aug 25.
9
A Case of Castleman's Disease during the Long-Term Course of Membranous Nephropathy.膜性肾病长期病程中并发Castleman病1例。
Case Rep Nephrol. 2023 Feb 22;2023:4926000. doi: 10.1155/2023/4926000. eCollection 2023.
10
Oral lichenoid lesion simultaneously associated with Castleman's disease and papillary thyroid carcinoma: a rare case report.口腔扁平苔藓样病变同时伴有 Castleman 病和甲状腺乳头状癌:一例罕见病例报告。
BMC Oral Health. 2022 Dec 7;22(1):572. doi: 10.1186/s12903-022-02623-2.
J Natl Compr Canc Netw. 2019 Nov;17(11.5):1417-1419. doi: 10.6004/jnccn.2019.5037.
4
Epidemiology of Castleman disease associated with AA amyloidosis: description of 2 new cases and literature review.Castleman 病相关淀粉样变性的流行病学:2 例新病例描述及文献复习。
Amyloid. 2019 Dec;26(4):197-202. doi: 10.1080/13506129.2019.1641078. Epub 2019 Jul 31.
5
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease.特发性多中心 Castleman 病的国际、循证共识治疗指南。
Blood. 2018 Nov 15;132(20):2115-2124. doi: 10.1182/blood-2018-07-862334. Epub 2018 Sep 4.
6
Sjögren's and plasma cell variant Castleman disease: a case report.干燥综合征与浆细胞型Castleman病:一例报告
Ghana Med J. 2018 Mar;52(1):61-65. doi: 10.4314/gmj.v52i1.9.
7
Primary Sjögren's Syndrome.原发性干燥综合征
N Engl J Med. 2018 Mar 8;378(10):931-939. doi: 10.1056/NEJMcp1702514.
8
Impact of siltuximab on patient-related outcomes in multicentric Castleman's disease.司妥昔单抗对多中心Castleman病患者相关结局的影响。
Patient Relat Outcome Meas. 2018 Jan 12;9:35-41. doi: 10.2147/PROM.S140011. eCollection 2018.
9
Treatment of Idiopathic Castleman Disease.特发性Castleman病的治疗
Hematol Oncol Clin North Am. 2018 Feb;32(1):89-106. doi: 10.1016/j.hoc.2017.09.008.
10
A rare case of renal thrombotic microangiopathy associated with Castleman's disease.一例与卡斯特曼病相关的罕见肾血栓性微血管病病例。
BMC Nephrol. 2017 Feb 10;18(1):57. doi: 10.1186/s12882-017-0472-2.